Medicare Enrolled
Dr. Benjamin Tripp, M.D.
Urology Physician · Delray Beach, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tripp from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tripp?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tripp
Dr. Benjamin Tripp is an urology physician in Delray Beach, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Tripp performed 45,113 Medicare services across 24,464 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tripp received a total of $2,104 from 23 pharmaceutical and/or device companies across 38 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tripp is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 2% volume in FL
$2,104 industry payments
Medicare Practice Summary
Medicare Utilization ↗45,113
Medicare services
Top 2% in FL for urology physician
24,464
Unique beneficiaries
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,374 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
5,589 | $2 | $17 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
5,562 | $8 | $15 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
3,811 | $8 | $22 |
| BCG treatment for bladder cancer | 3,201 | $2 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
3,169 | $68 | $185 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,377 | $8 | $15 |
| PSA test (prostate cancer screening) | 2,375 | $18 | $35 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,570 | $98 | $262 |
| Cell examination of specimen, concentration technique A laboratory test that uses a concentration technique to examine cells from a specimen. |
1,532 | $51 | $134 |
| Sex hormone binding globulin level test A blood test that measures the level of sex hormone binding globulin, a protein that binds to sex hormones in the bloodstream. |
1,521 | $21 | $60 |
| Follicle stimulating hormone (FSH) level A blood test to measure the level of follicle stimulating hormone, a reproductive hormone. |
1,520 | $18 | $32 |
| Luteinizing hormone level test A blood test that measures the level of luteinizing hormone, a reproductive hormone. This test helps evaluate hormonal balance and reproductive function. |
1,519 | $18 | $31 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
1,519 | $25 | $40 |
| Prolactin level test A blood test that measures the amount of prolactin, a hormone produced by the pituitary gland that stimulates milk production, in the body. |
1,516 | $19 | $33 |
| Complete pelvic ultrasound An imaging test using sound waves to create pictures of the organs and structures within the pelvis. |
1,169 | $82 | $216 |
| Limited abdominal ultrasound A focused ultrasound examination of the abdomen to evaluate specific organs or areas. This procedure uses sound waves to create images of internal structures. |
1,166 | $46 | $180 |
| Bladder cancer protein test A laboratory test that measures specific proteins to help diagnose and monitor bladder cancer. |
872 | $21 | $90 |
| Mitomycin injection, 5 mg Administration of a 5 mg dose of mitomycin medication via injection. |
858 | $49 | $150 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
659 | $103 | $407 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
432 | $130 | $344 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
365 | $191 | $494 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 294 | $136 | $893 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
276 | $17 | $47 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
270 | $97 | $246 |
| Manual urine cell examination A laboratory test where a technician manually examines a urine sample under a microscope to identify and count cells. |
239 | $48 | $142 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
179 | $66 | $182 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
159 | $61 | $158 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
154 | $631 | $1,607 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
137 | $57 | $144 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
113 | $6 | $262 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
112 | $142 | $359 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
98 | $25 | $133 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
98 | $65 | $163 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
97 | $312 | $791 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
97 | $152 | $389 |
| Injection, garamycin, gentamicin, up to 80 mg | 93 | $2 | $15 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
76 | $46 | $127 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
75 | $27 | $69 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
39 | $255 | $675 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
36 | $596 | $1,526 |
| Complicated insertion of bladder tube | 30 | $116 | $310 |
| Endoscopic destruction of bladder, urethra, or gland tissue A procedure that uses an endoscope to destroy tissue in the bladder, urethra, or surrounding glands. |
30 | $603 | $1,529 |
| Ultrasound of scrotum An imaging test that uses sound waves to create pictures of the scrotum and its contents. It helps evaluate the testicles and surrounding structures. |
29 | $57 | $208 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
25 | $108 | $273 |
| Insertion of temporary bladder tube | 15 | $37 | $94 |
| Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters. |
14 | $174 | $603 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
14 | $70 | $326 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
12 | $240 | $662 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
17.5% medium
82.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,104
Total received (2018-2024)
Avg $301/year across 7 years
Bottom 37% in FL for urology physician
23
Companies
38
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Other
Charitable contributions, space rental, and other categories
$1,103 (52.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$957 (45.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$44 (2.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$173
2023
$30
2022
$422
2021
$1,163
2020
$16
2019
$207
2018
$92
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Olympus America Inc.
$1,129
PROCEPT BioRobotics Corporation
$137
Astellas Pharma US Inc
$121
AbbVie, Inc.
$115
TOLMAR Pharmaceuticals, Inc.
$80
Boston Scientific Corporation
$60
United Service Solutions LLC
$59
Janssen Biotech, Inc.
$53
Medtronic, Inc.
$45
Antares Pharma, Inc.
$44
Astellas Pharma Global Development
$44
COLOPLAST CORP
$39
NeoTract Inc.
$21
Myovant Sciences Inc.
$19
Agiliti Surgical, Inc.
$17
ABBVIE INC.
$16
Verity Pharmaceuticals Inc.
$16
Endo Pharmaceuticals Inc.
$16
Novartis Pharmaceuticals Corporation
$15
Teleflex LLC
$15
PFIZER INC.
$15
Coloplast Corp
$15
DUSA Pharmaceuticals, Inc.
$13
Top 3 companies account for 65.9% of total payments
Associated products mentioned in payments ›
AQUABEAM ROBOTIC SYSTEM · CYSTO-NEPHRO VIDEOSCOPE · ELIGARD · ERLEADA · Erleada · INTERSTIM · Koelis TRINITY Fusion Biopsy System · LEVULAN KERASTICK · LUPRON DEPOT · Lupron Depot · NOCDURNA · ORGOVYX · PLUVICTO · Rezum Generator · SpeediCath · Trelstar · UROLIFT · UroLift · XIAFLEX · XTANDI · Xtandi · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Payments are distributed across multiple categories with no single dominant type.
Equivalent to $5 per 100 Medicare services performed
Geographic Context
Urology physicians within 10 mi
101
Per 100K population
6.7
County median income
$81,115
Nearest hospital
DELRAY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Tripp is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), with mixed engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Tripp experienced with automated urinalysis?
Based on Medicare claims data, Dr. Tripp performed 5,589 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tripp receive payments from pharmaceutical companies?
Yes. Dr. Tripp received a total of $2,104 from 23 companies across 38 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tripp's costs compare to other urology physicians in Delray Beach?
Dr. Tripp's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tripp) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Delray Beach
Browse urology physicians in Delray Beach ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in FL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in FL
Which FL urology physicians receive the most from drug and device companies.
By company
Olympus America Inc. Payments to Doctors
See all physicians who received payments from Olympus America Inc.
By company
PROCEPT BioRobotics Corporation Payments to Doctors
See all physicians who received payments from PROCEPT BioRobotics Corporation.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology